CSIMarket
 


Precigen Inc   (PGEN)
Other Ticker:  
 
 

PGEN's Revenue Growth by Quarter and Year

Precigen Inc 's Revenue results by quarter and year




PGEN Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -4.92 -24.75 24.22 23.58
III Quarter September 1.38 16.72 21.56 30.42
II Quarter June 1.77 2.91 33.58 29.84
I Quarter March 1.85 32.02 24.51 0.00
FY   0.08 26.90 103.87 83.84



PGEN Revenue fourth quarter 2023 Y/Y Growth Comment
Precigen Inc in the fourth quarter 2023 recorded of $ -4.92 millions.

According to the results reported in the fourth quarter 2023, Precigen Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Precigen Inc ' s Revenue no change of % ranks overall at the positon no. in the fourth quarter 2023.




PGEN Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - 2.71 % -
III Quarter September -91.75 % -22.45 % -29.13 % -
II Quarter June -39.18 % -91.33 % 12.53 % -
I Quarter March -94.22 % 30.64 % - -
FY   -99.71 % -74.1 % 23.89 % -

Financial Statements
Precigen Inc 's fourth quarter 2023 Revenue $ -4.92 millions PGEN's Income Statement
Precigen Inc 's fourth quarter 2022 Revenue $ -24.75 millions Quarterly PGEN's Income Statement
New: More PGEN's historic Revenue Growth >>


PGEN Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - 12.34 % -22.49 %
III Quarter September -22.03 % 474.57 % -35.8 % 1.94 %
II Quarter June -4.32 % -90.91 % 37.01 % -
I Quarter March - 32.2 % 3.94 % -
FY (Year on Year)   -99.71 % -74.1 % 23.89 % -




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Precigen Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PGEN's IV. Quarter Q/Q Revenue Comment
Recent accomplishment of -4.92 millions by Precigen Inc look even less good compare to the 1.38 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Precigen Inc achieved highest sequential Revenue growth. While Precigen Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PGEN's IV. Quarter Q/Q Revenue Comment
IV. Quarter 2023 accomplishment of -4.92 millions by Precigen Inc come out even more unfavourable if you take a look at 1.38 millions a quarter before.

Within Major Pharmaceutical Preparations industry Precigen Inc achieved highest sequential Revenue growth. While Precigen Inc 's Revenue growth quarter on quarter, overall rank is .


Precigen Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 0.08 $ -19.75 $ -4.41 $ -3.26 $ 26.91
Y / Y Revenue Growth (TTM) -99.72 % - - - -74.09 %
Year on Year Revenue Growth Overall Ranking # 2576 # 2576 # 2576 # 2576 # 4130
Seqeuential Revenue Change (TTM) - - - - -64.54 %
Seq. Revenue Growth (TTM) Overall Ranking # 2576 # 3713 # 3847 # 3823 # 4130




Cumulative Revenue growth Comment
Precigen Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Precigen Inc 's annual Revenue drop would be -99.72% year on year to $0 millions.

In the Healthcare sector 315 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2576, from total ranking in previous quarter at 3713.

Revenue TTM Q/Q Growth Statistics
High Average Low
2.79 %
-69.99 %
-126.03 %
(Mar 31 2022)  

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 113
Healthcare Sector # 316
Overall # 2547

Revenue TTM Y/Y Growth Statistics
High Average Low
2.79 %
-69.99 %
-126.03 %
(Mar 31 2022)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 113
Sector # 314
S&P 500 # 2541
Cumulative Revenue growth Comment
Precigen Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Precigen Inc 's annual Revenue drop would be -99.72% year on year to $0 millions.

In the Healthcare sector 315 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2576, from total ranking in previous quarter at 3713.

Revenue TTM Q/Q Growth Statistics
High Average Low
2.79 %
-69.99 %
-126.03 %
(Mar 31 2022)  


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 113
Healthcare Sector # 316
Overall # 2547

Revenue TTM Y/Y Growth Statistics
High Average Low
2.79 %
-69.99 %
-126.03 %
(Mar 31 2022)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 113
Sector # 314
S&P 500 # 2541




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PGEN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PGEN's Competitors
Revenue Growth for Precigen Inc 's Suppliers
Revenue Growth for PGEN's Customers

You may also want to know
PGEN's Annual Growth Rates PGEN's Profitability Ratios PGEN's Asset Turnover Ratio PGEN's Dividend Growth
PGEN's Roe PGEN's Valuation Ratios PGEN's Financial Strength Ratios PGEN's Dividend Payout Ratio
PGEN's Roa PGEN's Inventory Turnover Ratio PGEN's Growth Rates PGEN's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Healthcare Services Group Inc -0.04%$ -0.042 millions
Integra Lifesciences Holdings Corp-0.25%$ -0.247 millions
National Research Corporation-0.37%$ -0.375 millions
The Beauty Health Company-0.63%$ -0.633 millions
3m Company-0.82%$ -0.817 millions
Viatris Inc -1.00%$ -0.998 millions
Quest Diagnostics Inc-1.93%$ -1.929 millions
Koru Medical Systems Inc-2.16%$ -2.161 millions
Envista Holdings Corporation-2.30%$ -2.300 millions
Zynex inc -3.11%$ -3.114 millions
Baxter International Inc -3.55%$ -3.550 millions
Caribou Biosciences Inc -3.63%$ -3.629 millions
Gilead Sciences Inc -3.72%$ -3.722 millions
Lifevantage Corp-3.92%$ -3.921 millions
Avantor Inc -4.02%$ -4.022 millions
Escalon Medical Corp -4.53%$ -4.533 millions
Inovio Pharmaceuticals Inc -4.55%$ -4.553 millions
Optinose Inc -4.76%$ -4.756 millions
Cryoport inc -5.13%$ -5.133 millions
Hookipa Pharma inc -5.38%$ -5.378 millions
Abbvie inc -5.42%$ -5.423 millions
Hologic Inc-5.69%$ -5.688 millions
Encision Inc -6.08%$ -6.083 millions
Biogen Inc -6.20%$ -6.199 millions
Curis Inc -6.62%$ -6.616 millions
Bio rad Laboratories Inc -6.62%$ -6.621 millions
Charles River Laboratories International inc -7.85%$ -7.853 millions
Cara Therapeutics inc -7.88%$ -7.881 millions
Arcus Biosciences Inc -7.89%$ -7.889 millions
Qiagen N v -8.67%$ -8.666 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com